Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD

FHS
January 6, 2025
11:02 am

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD exacerbations and pneumonia risk.

Study reveals gaps in interconception care for Australian mothers

Some Australian mothers regard navigating their personal health care in between pregnancies as confusing, inconsistent, and hard to access, new research by a Monash University-led team

November 4, 2024

How Reasoning-Based AI Improves Care Transitions

Matt A. Murphy, CEO and Co-Founder of Cascala Health Joe Jasser, MD, MBA, Board Member for Cascala Health It’s human nature that when we are

December 19, 2024

Experts Believe Gene Therapy Offers Potential to Impact Gaucher Disease Market

Share this article KOLs have expressed enthusiastic support for gene therapy in the Gaucher disease drug market. Credit: metamorworks/Shutterstock. According to several key opinion leaders

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.